Nadolol and Bendroflumethiazide

Product NDC: 0115-5322
11-digit product format: 001155322
Labeler code: 0115
Product ID: 0115-5322_2669933a-33f4-478a-bd9d-9fe48429bcc9
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: NADOLOL and BENDROFLUMETHIAZIDE
Dosage form: TABLET
Route: ORAL
Labeler: Impax Generics
Application: ANDA077833
Marketing category: ANDA
Marketing start: 2007-03-30
Marketing end: 0000-00-00
Substance: NADOLOL; BENDROFLUMETHIAZIDE
Active strength: 80 mg/1; mg/1
Pharmacologic classes: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0115-5322		I	Inactivated by FDA	2026-09-14
excluded package	package	0115-5322	0115-5322-01	I	Inactivated by FDA	2026-09-14
excluded package	package	0115-5322	0115-5322-02	I	Inactivated by FDA	2026-09-14

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 63 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0115-5322-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0115-5322-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0115-5322-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0115-5322-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0115-5322-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0115-5322-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0115-5322-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0115-5322-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0115-5322-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0115-5322-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0115-5322-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0115-5322-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0115-5322-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0115-5322-02	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0115-5322-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0115-5322-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0115-5322-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0115-5322-02	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0115-5322-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0115-5322-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0115-5322-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0115-5322-02	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0115-5322-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0115-5322-02	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	0115-5322-01	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	0115-5322-02	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	0115-5322-01	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	0115-5322-02	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	0115-5322-01	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	0115-5322-02	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	0115-5322-01	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	0115-5322-02	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	0115-5322-01	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	0115-5322-02	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	0115-5322-01	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	0115-5322-02	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	0115-5322-01	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	0115-5322-02	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	0115-5322-01	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	0115-5322-02	`e2bbac7714bc…`	`27bdfed8d636…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	BENDROFLUMETHIAZIDE; NADOLOL	5MG;40MG	TABLET / ORAL			2007-03-30
A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	BENDROFLUMETHIAZIDE; NADOLOL	5MG;80MG	TABLET / ORAL			2007-03-30

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL		2007-03-30	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL		2007-03-30	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077833-001	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;40MG	TABLET / ORAL	AB	2007-03-30	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077833-002	NADOLOL AND BENDROFLUMETHIAZIDE	5MG;80MG	TABLET / ORAL	AB	2007-03-30	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A077833-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077833-002	AB	1	`74a2ff9319b5…`
2021-12-28 21:50 UTC	2021-12	A077833-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A077833-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077833-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077833-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A077833-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A077833-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A077833-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A077833-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A077833-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A077833-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077833-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A077833-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077833-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A077833-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077833-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A077833-002	AB	1	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c3e14ce3-3dd7-c88b-aff9-2af221ac8a37	Product name	9	20240606
8fcb295c-5817-6981-e90d-9999d4e8f347	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0115-5322-01	2020-01-31	C162847	48780-1	9d75b9cf-f3d4-f424-e053-dadaa90a57ce	NADOLOL AND BENDROFLUMETHIAZIDE TABLETS, USP, 40 mg/5 mg AND 80 mg/5 mg
0115-5322-02	2020-01-31	C162847	48780-1	9d75b9cf-f3d4-f424-e053-dadaa90a57ce	NADOLOL AND BENDROFLUMETHIAZIDE TABLETS, USP, 40 mg/5 mg AND 80 mg/5 mg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0115-5322-01	Nadolol and Bendroflumethiazide	100 in 1 BOTTLE	TABLET	100		6
0115-5322-02	Nadolol and Bendroflumethiazide	500 in 1 BOTTLE	TABLET	500		6

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0115-5322-01	EA - Each	0115-5322	3a36d339-80e3-46b4-9e75-90f97717b2b3	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
BENDROFLUMETHIAZIDE	ACTIVE INGREDIENT	5Q52X6ICJI	NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]	4
NADOLOL	ACTIVE INGREDIENT	FEN504330V	NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]	4
BENDROFLUMETHIAZIDE	ACTIVE MOIETY	5Q52X6ICJI	NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]	4
NADOLOL	ACTIVE MOIETY	FEN504330V	NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]	4
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]	4
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]	4
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]	4
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]	4
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]	4
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	NADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0115-5322	NADOLOL AND BENDROFLUMETHIAZIDE TABLET [IMPAX GENERICS]	6	Legacy NDC, 2 package rows	20160416_d2d226ea-1624-47ee-82bf-e9660b75029f.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
FEN504330V	NADOLOL	42200-33-9	NADOLOL
5Q52X6ICJI	BENDROFLUMETHIAZIDE	73-48-3	BENDROFLUMETHIAZIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
198000	nadolol 40 MG / bendroflumethiazide 5 MG Oral Tablet	PSN	d2d226ea-1624-47ee-82bf-e9660b75029f	6
198001	nadolol 80 MG / bendroflumethiazide 5 MG Oral Tablet	PSN	d2d226ea-1624-47ee-82bf-e9660b75029f	6
198000	bendroflumethiazide 5 MG / nadolol 40 MG Oral Tablet	SCD	d2d226ea-1624-47ee-82bf-e9660b75029f	6
198001	bendroflumethiazide 5 MG / nadolol 80 MG Oral Tablet	SCD	d2d226ea-1624-47ee-82bf-e9660b75029f	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
0115-5322-01	00115532201	100 in 1 BOTTLE	Historical
0115-5322-02	00115532202	500 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
NADOLOL AND BENDROFLUMETHIAZIDE TABLETS, USP, 40 mg/5 mg AND 80 mg/5 mg	Impax Generics \| Impax Laboratories, Inc \| Packaging Coordinators, LLC	2016-04-15	HUMAN PRESCRIPTION DRUG LABEL	6